Soliqua 100/33 Injection, Solution
Product Images NDC 0024-5761

Product Visual Gallery

This gallery contains 25 technical images submitted to the FDA as part of the official labeling for Soliqua 100/33 (NDC 0024-5761). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sanofi-aventis U.s. Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Soliqua 01)

A line graph comparing mean percentages over weeks for three treatments: INS/LIXI (blue squares), INS (red triangles), and LIXI (green stars). The x-axis represents weeks, and the y-axis shows mean percentages. Data points show decreases over time, with INS/LIXI generally lower than INS and LIXI. Below the graph is a table showing the number of subjects per treatment group at study intervals.*

FDA Label Image

Chemical Structure (Soliqua 02)

An instructional illustration showing recommended subcutaneous injection sites for Soliqua 100/33, indicating the upper arms, stomach, and thighs as suitable areas for administration.*

FDA Label Image

Image (Soliqua 03)

This illustration diagram shows a labeled insulin injection pen disassembled to reveal its parts for Soliqua 100/33, an insulin glargine and lixisenatide injection. It identifies components including the pen cap, cartridge holder with rubber seal, plunger, medicine scale, medicine name label, expiration date, dose window with dose selector and dose pointer, and the injection button.*

FDA Label Image

Image (Soliqua 04)

Soliqua 100/33 injection pen, an insulin glargine and lixisenatide combination for subcutaneous use. The pen is olive green with a white label panel showing the product name and concentration: 100 units/mL insulin glargine and 33 mcg/mL lixisenatide. Produced by Sanofi-Aventis U.S. LLC.*

FDA Label Image

Image (Soliqua 05)

An instructional illustration showing a hand holding a Soliqua 100/33 injection pen. The left image depicts the injection pen with the cap removed, while the right image shows the hand pushing the cap forward, indicated by a blue arrow, demonstrating how to remove or attach the pen cap before use.*

FDA Label Image

Image (Soliqua 06)

Soliqua 100/33 injection syringe label showing insulin glargine and lixisenatide combination. The label displays dosing increments and indicates the product is for single patient use only. Strengths noted are 100 units/mL of insulin glargine and 33 mcg/mL of lixisenatide.*

FDA Label Image

Image (Soliqua 07)

An instructional illustration showing a person using a cloth or wipe to clean the rubber stopper of a prefilled syringe or vial, held in one hand, while the other hand holds the cloth. This image is likely to demonstrate proper preparation before injection for a subcutaneous drug.*

FDA Label Image

Image (Soliqua 08)

An instructional black and white line drawing showing two hands preparing a medication vial or pen by placing or removing a cap or seal. The image likely demonstrates a step in the preparation or administration of an injection, relevant to subcutaneous delivery.*

FDA Label Image

Image (Soliqua 09)

Illustration showing how to remove the pen cap from a Soliqua 100/33 insulin glargine and lixisenatide injection pen before use. The image features hands holding the pen and pulling the cap off with directional arrows indicating the motion. An inset depicts a close-up, warning not to twist the cap off but to pull it straight.*

FDA Label Image

Image (Soliqua 10)

An instructional diagram showing a hand holding a Soliqua 100/33 injection pen while another hand is pulling the cap off the pen needle. The image illustrates the step of removing the protective needle cap before injection.*

FDA Label Image

Image (Soliqua 11)

An instructional illustration showing a hand removing the cap from a vial while holding a syringe with a needle above it, indicating preparation for injection.*

FDA Label Image

Image (Soliqua 12)

An instructional illustration showing a hand holding a Soliqua 100/33 injection pen with another hand rotating the dosing knob. A zoomed inset highlights the dose display indicator on the pen to guide dose setting for subcutaneous injection.*

FDA Label Image

Image (Soliqua 13)

An instructional illustration showing hands holding a Soliqua 100/33 injection pen. The image highlights a step where fluid is being expelled from the needle tip to remove air, indicated by a close-up view of a droplet emerging from the needle.*

FDA Label Image

Image (Soliqua 14)

An instructional illustration showing a hand holding a Soliqua 100/33 injection pen. The pen is marked with dosage and has a thumb pressing on the injection end, demonstrating the subcutaneous injection technique for this insulin glargine and lixisenatide solution.*

FDA Label Image

Image (Soliqua 15)

Soliqua 100/33 injection pen syringe with insulin glargine and lixisenatide, solution for subcutaneous use. The pen displays measurement markings and label with strength 100 U/mL insulin glargine and 33 mcg/mL lixisenatide. Labeler is Sanofi-Aventis U.S. LLC. Product NDC 0024-5761.*

FDA Label Image

Image (Soliqua 16)

Illustration showing a close-up view of a dosing selector dial with numbers 28, 30, and 32 prominently visible, suggesting adjustment increments on a dosage device for an injectable medication.*

FDA Label Image

Image (Soliqua 17)

An illustration showing a close-up of an insulin pen dose selector window displaying the numbers 28 to 30, indicating dose selection in units.*

FDA Label Image

Image (Soliqua 18)

An instructional diagram showing a hand holding a Soliqua 100/33 injection pen with the needle facing left. The illustration indicates pulling the injection pen back with a blue arrow to prepare the injection. The pen has a dosage dial highlighted in olive green and an orange cap on the right end.*

FDA Label Image

Image (Soliqua 19)

An instructional diagram showing a hand holding a Soliqua 100/33 injection pen. The image highlights proper use of the dose knob, indicating to pull it straight out with a blue arrow and a circle around the correct grip, and includes a red marked illustration warning against twisting or incorrect handling of the dose knob.*

FDA Label Image

Image (Soliqua 20)

An instructional diagram showing a hand holding an injection pen labeled Soliqua 100/33. The image emphasizes a close-up of the injection pen's tip with a clock icon indicating a 10-second count, likely demonstrating the recommended time to hold the pen after injection for proper administration.*

FDA Label Image

Image (Soliqua 21)

An instructional illustration showing a hand holding a Soliqua 100/33 injection pen and another hand removing or attaching the pen cap, indicated by a blue arrow. The pen displays a label with partial text and dosage markings on the side.*

FDA Label Image

Image (Soliqua 22)

An instructional illustration showing proper use of the Soliqua 100/33 injection pen, featuring hands holding the pen and an arrow indicating to rotate or twist the cap for preparation before subcutaneous injection.*

FDA Label Image

Image (Soliqua 23)

Illustration showing hands removing a foil seal from a bottle and unscrewing the bottle cap. The image demonstrates how to open the bottle cap by first peeling off the seal and then twisting the cap counterclockwise to open.*

FDA Label Image

Image (Soliqua 24)

An instructional illustration showing how to remove the cap from a Soliqua 100/33 injection pen. A left hand holds the pen body with dosing window visible, and the right hand pulls the cap straight off to the left, indicated by a blue arrow.*

FDA Label Image

Image (Soliqua 25)

Packaging label for Soliqua 100/33 injection, a subcutaneous solution containing insulin glargine 100 units/mL and lixisenatide 33 mcg/mL. The label shows brand name, active ingredients, strength, usage instructions, and manufacturer Sanofi-Aventis U.S. LLC. The carton includes space for five 3 mL prefilled pens and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.